Patents by Inventor Anne Gompel

Anne Gompel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR THE PROGNOSIS AND TREATMENT OF ENDOMETRIAL CARCINOMA
    Publication number: 20190015503
    Abstract: The present invention relates to methods for predicting the survival time of patients from endometrial adenocarcinoma. The present invention also relates to methods and pharmaceutical compositions for the treatment of endometrial adenocarcinoma.
    Type: Application
    Filed: July 13, 2016
    Publication date: January 17, 2019
    Inventors: Patricia Forgez, Anne Gompel
  • Ulipristal acetate for prevention and treatment of breast tumors
    Patent number: 9814732
    Abstract: The invention relates to the use of ulipristal acetate, or any of its metabolites, in preventing or treating a breast tumor in a patient, preferably a patient that carries a mutation in BRCA1 gene.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: November 14, 2017
    Assignees: Laboratoire HRA-PHARMA, INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Michele Resche-Rigon, Delphine Levy, Erin Gainer, Anne Gompel, Patricia Forgez, Laudine Desreumaux-Communal
  • ULIPRISTAL ACETATE FOR PREVENTION AND TREATMENT OF BREAST TUMORS
    Publication number: 20170014426
    Abstract: The invention relates to the use of ulipristal acetate, or any of its metabolites, in preventing or treating a breast tumor in a patient, preferably a patient that carries a mutation in BRCA1 gene.
    Type: Application
    Filed: July 29, 2016
    Publication date: January 19, 2017
    Inventors: Michele RESCHE-RIGON, Delphine LEVY, Erin GAINER, Anne GOMPEL, Patricia FORGEZ, Laudine DESREUMAUX-COMMUNAL
  • ULIPRISTAL ACETATE FOR PREVENTION AND TREATMENT OF BREAST TUMORS
    Publication number: 20150133418
    Abstract: The invention relates to the use of ulipristal acetate, or any of its metabolites, in preventing or treating a breast tumor in a patient, preferably a patient that carries a mutation in BRCA1 gene.
    Type: Application
    Filed: May 24, 2013
    Publication date: May 14, 2015
    Inventors: Michele Resche-Rigon, Delphine Levy, Erin Gainer, Anne Gompel, Patricia Forgez, Laudine Desreumaux-Communal
  • METHODS FOR SCREENING A BRCA1 LOSS-OF-FUNCTION IN A SUBJECT SUFFERING FROM A CANCER
    Publication number: 20140296281
    Abstract: The present invention relates to a method for screening a BRCA1 loss-of-function in a subject comprising the step consisting of determining the level of serine 211 phosphorylated glucocorticoid receptor (GR P-Ser211) expression in a tissue sample obtained from said subject.
    Type: Application
    Filed: November 26, 2012
    Publication date: October 2, 2014
    Inventors: Anne Gompel, Patricia Forgez
  • Methods for treating breast cancer with inhibitors of neurotensin activation of NTSR1
    Patent number: 8586043
    Abstract: The present invention relates to methods for the treatment, the prognostic assessment and the detection of breast cancer.
    Type: Grant
    Filed: January 5, 2010
    Date of Patent: November 19, 2013
    Assignee: INSERM ( Institut National de la Sante et de la Recherche Medicale)
    Inventors: Patricia Forgez, Anne Gompel
  • Methods for Treatment, the Prognostic Assessment and the Detection of Breast Cancer
    Publication number: 20110305633
    Abstract: The present invention relates to methods for the treatment, the prognostic assessment and the detection of breast cancer.
    Type: Application
    Filed: January 5, 2010
    Publication date: December 15, 2011
    Applicant: INSERM(Institut National de la Sante et de la Recherche Medicale)
    Inventors: Patricia Forgez, Anne Gompel